The Cigarette and the Sperm: A Fatal Liaison?

Proteomic analysis of the urothelial cancer landscape.

Nature communications·2024

Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.

Orphanet journal of rare diseases·2019

Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2019

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11).

European journal of cancer (Oxford, England : 1990)·2018

Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.

World journal of urology·2018

Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.

European journal of nuclear medicine and molecular imaging·2018

Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

European urology·2026

Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial.

European urology·2026

Hereditary Renal Cancer Syndromes: Redefining Clinical Management in the Era of Precision Medicine.

European urology·2026

PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

European urology·2026

EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer.

European urology·2026

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.

European urology·2026

[Omnipresent Lactate: Normalization of the Tumor Microenvironment as a Prerequisite for Any Anticancer Therapy].

Molekuliarnaia biologiia·2026

Liver cirrhosis is associated with altered glucocorticoid metabolism related to disease severity.

Journal of internal medicine·2026

Clinical Significance and Subtype Distribution of Blastocystis Infection with Colonoscopy Findings.

Iranian journal of parasitology·2026

Liver-kidney crosstalk in primary biliary cholangitis: insights into the mechanisms of renal involvement.

Frontiers in immunology·2026

Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease models.

Alternatives to laboratory animals : ATLA·2026

Lipid-Rich Urothelial Carcinoma: A Contemporary Clinicopathologic Study of 40 Patients With Transcriptional Tumor Profiling.

The American journal of surgical pathology·2026

Related Experiment Videos

The Cigarette and the Sperm: A Fatal Liaison?

Related Concept Videos

Proteomic analysis of the urothelial cancer landscape.

Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.

Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11).

Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.

Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.

Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial.

Hereditary Renal Cancer Syndromes: Redefining Clinical Management in the Era of Precision Medicine.

PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer.

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.

[Omnipresent Lactate: Normalization of the Tumor Microenvironment as a Prerequisite for Any Anticancer Therapy].

Liver cirrhosis is associated with altered glucocorticoid metabolism related to disease severity.

Clinical Significance and Subtype Distribution of Blastocystis Infection with Colonoscopy Findings.

Liver-kidney crosstalk in primary biliary cholangitis: insights into the mechanisms of renal involvement.

Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease models.

Lipid-Rich Urothelial Carcinoma: A Contemporary Clinicopathologic Study of 40 Patients With Transcriptional Tumor Profiling.

Related Experiment Videos

The Cigarette and the Sperm: A Fatal Liaison?

Related Concept Videos

Related Articles